No large investors shut out of MPS stake placement in November, Akros says-February 2024-www.financetom.com

No large investors shut out of MPS stake placement in November, Akros says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

No large investors shut out of MPS stake placement in November, Akros says

Jun 24, 2025 3:33 AM

MILAN, June 24 (Reuters) - Italy's Banca Akros, the

investment bank of Banco BPM, said on Tuesday that no

large investors were shut out of the placement it handled in

November of a 15% stake in Monte dei Paschi on behalf

of the Rome government.

This includes UniCredit, Norway's oil fund and

BlackRock ( BLK ), Banca Akros added in a statement.

Previous page： Transocean Secures $531 Million Contract With BP Next page： New Boeing boss Kelly Ortberg brings engineering background, aerospace roots

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Transocean Secures $531 Million Contract With BP

Jul 31, 2024

11:04 AM EDT, 07/31/2024 (MT Newswires) -- Transocean ( RIG ) said Wednesday that it secured a contract with BP (BP) for its Deepwater Invictus drillship, which is estimated to contribute about $531 million in backlog. The company said the 1,095-day contract is for a drilling program in the US Gulf of Mexico that is expected to start in Q1...

New Boeing boss Kelly Ortberg brings engineering background, aerospace roots

Jul 31, 2024

(Reuters) - Kelly Ortberg, the former Rockwell Collins boss coming out of retirement to take the reins of Boeing ( BA ), is known as an aerospace veteran with an engineering background that contrasts with the troubled planemaker's former leadership. Ortberg will have a lengthy to-do list when he starts on Aug. 8. He'll have to strengthen relations between Boeing...

IDEAYA Biosciences, Biocytogen Agree to Option, License Deal for Solid Tumors Treatment Program

Jul 31, 2024

11:03 AM EDT, 07/31/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Wednesday it has agreed to an option and license deal with Biocytogen Pharmaceuticals for a potential solid tumors treatment program. Under the agreement, IDEAYA will pay up to $406.5 million to Biocytogen, which includes upfront, option exercise and milestone payments. Development and regulatory milestone payments amount to...

--SunCoke Energy Raises Quarterly Dividend 20% to $0.12 Per Share, Payable Sept. 3 to Shareholders on Aug. 15

Jul 31, 2024

11:04 AM EDT, 07/31/2024 (MT Newswires) -- Price: 11.73, Change: +0.86, Percent Change: +7.87 ...